About Careers Internship MedBlog Contact us

Ability of Biomarkers to Improve Prediction of Cardiovascular Risk is Not Significant

by Rajashri on July 1, 2009 at 9:49 PM
 Ability of Biomarkers to Improve Prediction of Cardiovascular Risk is Not Significant

A study led by investigators at Massachusetts General Hospital (MGH) and Lund University in Sweden says that measurement of known biomarkers of cardiovascular disease slightly improves the ability to predict future heart attack or stroke in healthy individuals, but not enough to change preventive therapies. It appears in the July 1 Journal of the American Medical Association.

"While there currently does not appear to be a role for routine use of biomarkers in screening for cardiovascular risk, our data do not exclude a role for biomarkers in selected patients," says Thomas Wang, MD, of the MGH Heart Center, the study's senior and co-corresponding author. "We're still optimistic that new technologies will lead to the discovery of biomarkers that could help us move toward offering truly personalized cardiovascular risk prediction."


Although conventional risk factors - such as smoking, hypertension, cholesterol levels and age - can identify individuals at the highest risk for heart attack or stroke, many people without these factors still experience these potentially devastating events. Since preventive measures such as lifestyle modification and the use of statin drugs to control elevated cholesterol can reduce risk, the authors note, it is essential to identify people whose risk could be reduced by behavioral or therapeutic steps. Some previous studies of the prediction of cardiovascular risk by biomarkers - laboratory measurements reflecting biological states that could have prognostic utility - focused on groups already known to be at high risk and others did not examine whether information provided by biomarkers could actually change an individual's risk classification. The current study was designed to address those limitations.

The investigators focused on two biomarkers that have been extensively studied in cardiovascular disease - C-reactive protein (CRP) and N-terminal pro-B-type natriuretic peptide (N-BNP) - and four that recently have been identified as relating to cardiovascular risk - Cystatin C, Lp-PLA2, MR-proADM and MR-proANP. They enrolled more than 5,000 participants in the Malmö Diet and Cancer Study (MDC), an ongoing prospective study based at Lund University, for whom both complete conventional cardiovascular risk data and plasma samples were available. The investigators analyzed plasma levels of the six biomarkers in samples taken when participants entered the MDC and then, using a personal identification number assigned to each Swedish citizen, searched for information on subsequent coronary and cardiovascular events in databases on hospital discharges, strokes and causes of death occurring over a period averaging almost 13 years.

Two of the studied biomarkers - N-BNP and MR-proADM - did significantly improve the prediction of coronary events, defined as a heart attack or death from ischemic heart disease. N-BNP and C-reactive protein improved the prediction of cardiovascular events, which are coronary events plus strokes. But when the ability of biomarkers to move individual patients into higher- or lower-risk categories was analyzed, the potential impact on treatment decisions was minimal.

"Since choice of therapies may depend on the risk category a patient falls into, moving patients between risk categories could lead to a change in therapy," explains co-author Christopher Newton-Cheh, MD, MPH, MGH Heart Center. "While there was more category movement among participants initially classified as intermediate-risk, that resulted primarily from movement to lower risk levels, so we still need to find biomarkers that can make a clinically significant difference in predicting cardiovascular risk." Wang and Newton-Cheh are both assistant professors of Medicine at Harvard Medical School.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Heart Disease News

Link Between Obesity and Elevated Bad Cholesterol Heightens Heart Disease Threat
The inflammation associated with obesity worsens the impairment of 'bad cholesterol,' increasing the chances of experiencing heart disease conditions.
Does Climbing Five Stair Flights Daily Cut Heart Disease Risk?
Daily stair climbing particularly lowered the risk of cardiovascular disease in individuals with lower susceptibility.
Link Between Cannabis Use Disorder and Heart Problem Risk
The research adds to the ongoing discussion concerning the health consequences of cannabis use disorder and its possible associations with heart disease
Why Heart Attacks Surge Among School-Aged Children?
Dietary choices and a sedentary lifestyle are major factors in the rise of heart attacks among school-aged children.
1,250 New Heart Attacks in People Under 35 Reported in Bangalore in 2 Years
In the past two years, the Bangalore PCAD registry reported over 2,500 heart attack cases in individuals under 40, with 1,250 of them under 35.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Ability of Biomarkers to Improve Prediction of Cardiovascular Risk is Not Significant Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests